HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

methoxyphenyl piperazinyl

structure

Also Known As:

3-(4-o-methoxyphenyl)-1-piperazinyl-4'- p-morpholinopropiophenone dihydrochloride; SU17595 A

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Ketones: 2618
  - Propiophenones: 1
    - methoxyphenyl piperazinyl: 4

Experts

1.	Chen, Kai-Feng: 1 article (03/2020)
2.	Dai, Li-Jun: 1 article (03/2020)
3.	Huang, Jun-Jun: 1 article (03/2020)
4.	Jiang, Ru-Chao: 1 article (03/2020)
5.	Liu, Qi-Meng: 1 article (03/2020)
6.	Liu, Xia-Wen: 1 article (03/2020)
7.	Shi, Jun-Min: 1 article (03/2020)
8.	Wu, Dan: 1 article (03/2020)
9.	Xiao, Qing: 1 article (03/2020)
10.	Zhu, Xiang: 1 article (03/2020)

Related Diseases

1.	Dyskinesias (Dyskinesia) 11/01/2006 - "Effect of the D(3) dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on l-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeys. " 11/01/2004 - "Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on L-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeys."
2.	Parkinsonian Disorders (Parkinsonism) 11/01/2006 - "Effect of the D(3) dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on l-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeys. " 11/01/2004 - "Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on L-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeys."
3.	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 12/01/2018 - "Naftopidil ((±)-1-[4-(2-methoxyphenyl) piperazinyl]-3-(1-naphthyloxy) propan-2-ol) is prescribed in several Asian countries for lower urinary tract symptoms suggestive of benign prostatic hyperplasia. " 03/05/2020 - "Inhibitory effect of α1D/1A antagonist 2-(1H-indol-3-yl)-N-[3-(4-(2-methoxyphenyl) piperazinyl) propyl] acetamide on estrogen/androgen-induced rat benign prostatic hyperplasia model in vivo."
4.	Lower Urinary Tract Symptoms 12/01/2018 - "Naftopidil ((±)-1-[4-(2-methoxyphenyl) piperazinyl]-3-(1-naphthyloxy) propan-2-ol) is prescribed in several Asian countries for lower urinary tract symptoms suggestive of benign prostatic hyperplasia. "

Related Drugs and Biologics

1.	Dopamine Receptors (Dopamine Receptor)
2.	Estrogens (Estrogen)
3.	Androgens
4.	naftopidil
5.	acetamide